热搜词：
注册
登录
CN
  • CN
  • EN

产品中心 抗体 Biosimilar抗体

所有图片（1/1）

Anti-PD-L1 Monoclonal Antibody(Atezolizumab)

Programmed cell death 1 ligand 1,PDCD1 ligand 1,Programmed death ligand 1,hPD-L1,B7 homolog 1,B7-H1,CD274,B7H1,PDCD1L1,PDCD1LG1

价格 ￥1,750.00 （ 供应商现货 ： 3-5个工作日）
货号 S0B0555
规格
数量
收藏 分享
产品介绍

产品介绍 评论(0)

产品规格

  • 宿主来源

    Human

  • 抗原名称

    PD-L1

  • 分子别名

    Programmed cell death 1 ligand 1, PDCD1 ligand 1, Programmed death ligand 1, hPD-L1, B7 homolog 1, B7-H1, CD274, B7H1, PDCD1L1, PDCD1LG1

  • Accession

    Q9NZQ7

  • 克隆号

    S-SC015

  • 抗体类型

    Recombinant mAb

  • 抗体同种型

    IgG1,k

  • 纯化方式

    Protein A

  • 浓度

    2 mg/ml

  • 内毒素含量

    <1EU/mg

  • 标记

    Unconjugated

  • 性状

    Liquid

  • 缓冲体系

    PBS pH7.4, containing no preservative

  • 储存条件

    12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

  • 应用

    Blocking of PD-1/PD-L1 signaling Functional assays

  • 稀释度

    应用 稀释度
    ELISA 1.221-5000 ng/ml
背景介绍

  • Atezolizumab, sold under the brand name Tecentriq, is a monoclonal antibody medication used to treat urothelial carcinoma, non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), hepatocellular carcinoma and alveolar soft part sarcoma. It is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1).

  • ELISA

    • Immobilized PD-L1 His Tag Protein, Human(UA010001) can bind Atezolizumab.The EC50 for this effect is 32.66 ng/mL.

评论(0)